MCID: ANT006
MIFTS: 58

Antiphospholipid Syndrome malady

Categories: Genetic diseases, Rare diseases, Immune diseases

Aliases & Classifications for Antiphospholipid Syndrome

About this section

Aliases & Descriptions for Antiphospholipid Syndrome:

Name: Antiphospholipid Syndrome 11 48 25 49 50 39 13 68
Antiphospholipid Antibody Syndrome 11 48 25
Hughes Syndrome 48 25 49
Familial Antiphospholipid Syndrome 48 68
 
Acromegaloid Facial Appearance Syndrome 68
Lupus Anticoagulant, Familial 48
Anti-Phospholipid Syndrome 25
Aps 48

Classifications:



External Ids:

Disease Ontology11 DOID:2988
ICD1030 D68.61
MeSH39 D016736
NCIt45 C61283

Summaries for Antiphospholipid Syndrome

About this section
NIH Rare Diseases:48 Antiphospholipid syndrome (APS) is an autoimmune disorder. Signs and symptoms vary, but may include blood clots, miscarriage, rash, chronic headaches, dementia, and seizures. APS occurs when your body's immune system makes antibodies that attack phospholipids. Phospholipids are a type of fat found in all living cells, including blood cells and the lining of blood vessels. Most cases of APS occur in people with no family history of the disorder, however there are rare cases of APS clustering in a family. A widely accepted explanation for APS is that it is caused by a combination of gene mutations (making one more susceptible to APS) and an environmental exposure (such as to a virus). Currently there is not a cure for APS. The goal of treatment is to prevent blood clots from forming and to keep existing clots from getting larger. Last updated: 5/25/2016

MalaCards based summary: Antiphospholipid Syndrome, also known as antiphospholipid antibody syndrome, is related to typhoid fever and splenic infarction, and has symptoms including migraine, spontaneous abortion and cutis marmorata. An important gene associated with Antiphospholipid Syndrome is APOH (Apolipoprotein H), and among its related pathways are Warfarin Pathway, Pharmacodynamics and AGE-RAGE signaling pathway in diabetic complications. Affiliated tissues include brain, endothelial and testes, and related mouse phenotypes are integument and normal.

Disease Ontology:11 A hypersensitivity reaction type II disease that is characterized by recurrent venous or arterial thrombosis and/or fetal losses associated with characteristic elevated levels of antibodies directed against membrane anionic phospholipids (anticardiolipin).

Genetics Home Reference:25 Antiphospholipid syndrome is a disorder characterized by an increased tendency to form abnormal blood clots (thromboses) that can block blood vessels. This clotting tendency is known as thrombophilia. In antiphospholipid syndrome, the thromboses can develop in nearly any blood vessel in the body, but most frequently occur in the vessels of the lower limbs. If a blood clot forms in the vessels in the brain, blood flow is impaired and can lead to stroke. Antiphospholipid syndrome is an autoimmune disorder. Autoimmune disorders occur when the immune system attacks the body's own tissues and organs.

NINDS:49 Antiphospholipid syndrome (APS) is an autoimmune disorder caused when antibodies -- immune system cells that fight off bacteria and viruses -- mistakenly attack healthy body tissues and organs.

Wikipedia:71 Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), or often also Hughes... more...

Related Diseases for Antiphospholipid Syndrome

About this section

Diseases in the Antiphospholipid Syndrome family:

Antiphospholipid Syndrome, Familial

Diseases related to Antiphospholipid Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 439)
idRelated DiseaseScoreTop Affiliating Genes
1typhoid fever30.3F2, MTHFR
2splenic infarction30.1CD40LG, F2, F3
3hemolytic anemia30.0ANXA5, CD40LG, CD79A
4heart disease29.7CD40LG, CD79A
5arteriosclerosis29.6CD40LG, CD79A
6thrombophilia29.5APOH, F2, F5, MTHFR, SERPINC1
7artery disease29.3CD40LG, CD79A, F2, F3
8budd-chiari syndrome29.3APOH, F2, F5, MTHFR, SERPINC1
9dermatitis29.2F2, F3, MTHFR, SERPINC1
10adult respiratory distress syndrome28.7F2, F3, PLAT, SELP, SERPINC1
11systemic lupus erythematosus28.3ADAMTS13, ANXA5, APOH, CD40LG, CD79A, F2
12peripheral artery disease28.3F2, F3, MTHFR, PLAT, SELE, SELP
13angina pectoris27.4F2, F3, PLAT, SELE, SELP, SERPINC1
14myocardial infarction26.2ADAMTS13, ANXA5, F10, F2, F3, F5
15catastrophic antiphospholipid syndrome12.3
16antiphospholipid syndrome, familial12.1
17neonatal antiphospholipid syndrome11.9
18x-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome10.9
19familial glomangioma10.7F2, F3
20coenzyme q cytochrome c reductase deficiency of10.7APOH, F5
21brown's tendon sheath syndrome10.7APOH, CD40LG
22onychocytic matricoma10.7APOH, F5
23perinatal necrotizing enterocolitis10.7APOH, CD40LG
24cerebral angioma10.7F2, F3
25cholesterol embolism10.7APOH, F2
26von willibrand disease, type 310.7F2, F3
27brill-zinsser disease10.7F2, F3
28rasa1-related disorders10.7F2, MTHFR
29acquired fructose intolerance10.6F3, F5
30epididymo-orchitis10.6F2, F3
31michels caskey syndrome10.6F5, MTHFR
32congenital stenosis of the inferior vena cava10.6F5, MTHFR
33ameloblastic carcinoma10.6F5, MTHFR
34bartholin's gland adenoma10.6F2, F5
35central nervous system germinoma10.5F2, F3
36chorea gravidarum10.5CD40LG, F2, F3
37congenital nystagmus10.5CD40LG, F2, F3
38beach ear10.5CD40LG, PLAT
39facioscapulohumeral muscular dystrophy 110.5F2, F3, F5
40peroneal neuropathy10.5F2, F3
41idiopathic central precocious puberty10.5F2, F3, F5
42infantile-onset ascending hereditary spastic paralysis10.5F2, F3, F5
43pregnancy loss, recurrent 110.5APOH, F5, MTHFR
44asphyxia neonatorum10.4APOH, SELE
45cavernous sinus thrombosis10.4F3, SERPINC1
46acute zonal occult outer retinopathy10.4F2, F5, MTHFR
47diphyllobothriasis10.4CD40LG, SERPINC1
48dislocation of ear ossicle10.4F2, F3, SELP
49thalassemia-beta, dominant inclusion-body10.4CD40LG, F2, MTHFR
50mesangioproliferative glomerulopathy10.4PLAT, THBD

Graphical network of the top 20 diseases related to Antiphospholipid Syndrome:



Diseases related to antiphospholipid syndrome

Symptoms & Phenotypes for Antiphospholipid Syndrome

About this section

Human phenotypes related to Antiphospholipid Syndrome:

 64 (show all 35)
id Description HPO Frequency HPO Source Accession
1 migraine64 hallmark (90%) HP:0002076
2 spontaneous abortion64 hallmark (90%) HP:0005268
3 cutis marmorata64 typical (50%) HP:0000965
4 abnormality of the heart valves64 typical (50%) HP:0001654
5 coronary artery disease64 typical (50%) HP:0001677
6 subcutaneous hemorrhage64 typical (50%) HP:0001933
7 memory impairment64 typical (50%) HP:0002354
8 cerebral ischemia64 typical (50%) HP:0002637
9 abnormality of the endocardium64 typical (50%) HP:0004306
10 thrombophlebitis64 typical (50%) HP:0004418
11 renal insufficiency64 occasional (7.5%) HP:0000083
12 proteinuria64 occasional (7.5%) HP:0000093
13 visual impairment64 occasional (7.5%) HP:0000505
14 seizures64 occasional (7.5%) HP:0001250
15 hyperreflexia64 occasional (7.5%) HP:0001347
16 portal hypertension64 occasional (7.5%) HP:0001409
17 hypertrophic cardiomyopathy64 occasional (7.5%) HP:0001639
18 thrombocytopenia64 occasional (7.5%) HP:0001873
19 abnormality of coagulation64 occasional (7.5%) HP:0001928
20 abnormality of extrapyramidal motor function64 occasional (7.5%) HP:0002071
21 chorea64 occasional (7.5%) HP:0002072
22 pulmonary hypertension64 occasional (7.5%) HP:0002092
23 abnormality of the pleura64 occasional (7.5%) HP:0002103
24 hemoptysis64 occasional (7.5%) HP:0002105
25 pulmonary infiltrates64 occasional (7.5%) HP:0002113
26 hepatomegaly64 occasional (7.5%) HP:0002240
27 paresthesia64 occasional (7.5%) HP:0003401
28 dermal atrophy64 occasional (7.5%) HP:0004334
29 hemiplegia/hemiparesis64 occasional (7.5%) HP:0004374
30 gastrointestinal infarctions64 occasional (7.5%) HP:0005244
31 aseptic necrosis64 occasional (7.5%) HP:0010885
32 hemiballismus64 occasional (7.5%) HP:0100248
33 hypertensive crisis64 occasional (7.5%) HP:0100735
34 gangrene64 occasional (7.5%) HP:0100758
35 skin ulcer64 occasional (7.5%) HP:0200042

UMLS symptoms related to Antiphospholipid Syndrome:


mahler sign

MGI Mouse Phenotypes related to Antiphospholipid Syndrome according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107718.0CD40LG, F2, F3, F5, MTHFR, SELE
2MP:00028737.8ADAMTS13, ANXA5, CD79A, F2, F3, SELE
3MP:00036317.1CD40LG, CD79A, F2, F3, F5, MTHFR
4MP:00053857.1CD40LG, F10, F2, F3, F5, PLAT
5MP:00053976.7ADAMTS13, ANXA5, CD40LG, CD79A, F2, F3
6MP:00053876.6ADAMTS13, ANXA5, CD40LG, CD79A, F2, F3
7MP:00107686.0ADAMTS13, APOH, CD40LG, F10, F2, F3
8MP:00053765.6ADAMTS13, APOH, CD40LG, CD79A, F10, F2

Drugs & Therapeutics for Antiphospholipid Syndrome

About this section

Drugs for Antiphospholipid Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 102)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Heparinapproved, investigationalPhase 4, Phase 1, Phase 28129005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Unfractionated heparin
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin
2
DalteparinapprovedPhase 4, Phase 23039041-08-1
Synonyms:
Daltepariininatrium
Dalteparin Sodyum
Dalteparin sodium
Dalteparin sodná sůl
Dalteparin-nátrium
Dalteparina sódica
 
Dalteparinnatrium
Dalteparino natrio druska
Dalteparinum Natricum
Dalteparyna sodowa
Daltéparine sodique
Heparin Fragment KABI 2165
Tedelparin
3
AcetaminophenapprovedPhase 4, Phase 1978103-90-21983
Synonyms:
4'-Hydroxyacetanilide
4'-hydroxyacetanilide
4-(Acetylamino)phenol
4-Acetamidophenol
4-Acetaminophenol
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
4-acetamidophenol
A-Per
A.F. Anacin
AC1Q1KYJ
AC1Q1KYK
APAP
Abenol
Abensanil
Abrol
Abrolet
Acamol
Accu-Tap
Acenol
Acephen
Acertol
Aceta Elixir
Aceta Tablets
Acetaco
Acetagesic
Acetalgin
Acetaminofen
Acetaminophen
Acetaminophen Uniserts
Acetamol
Acetavance
Acetofen
Actamin
Actamin Extra
Actamin Super
Actifed Plus
Actimol
Actimol Chewable Tablets
Actimol Children'S Suspension
Actimol Infants' Suspension
Actimol Junior Strength Caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen Max
Anacin
Anacin 3
Anacin-3
Anacin-3 Extra Strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
Anhiba
Anoquan
Anti-Algos
Antidol
Anuphen
Apacet
Apacet Capsules
Apacet Elixir
Apacet Extra Strength Caplets
Apacet Extra Strength Tablets
Apacet Regular Strength Tablets
Apadon
Apamid
Apamide
Apitrelal
Apo-Acetaminophen
Arfen
Arthralgen
Asetam
Asomal
Aspac
Aspirin Free Anacin Maximum Strength Caplets
Aspirin Free Anacin Maximum Strength Gel Caplets
Aspirin Free Anacin Maximum Strength Tablets
Aspirin-Free Anacin
Aspirin-Free Excedrin Caplets
Asplin
Atasol
Atasol Caplets
Atasol Drops
Atasol Forte Caplets
Atasol Forte Tablets
Atasol Oral Solution
Atasol Tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap Hc
Banesin
Bayer Select
Bayer Select Allergy-Sinus
Bayer Select Head Cold
Bayer Select Headache Pain
Bayer Select Maximum Strength Headache Pain Relief Formula
Bayer Select Menstrual Multi-Symptom
Bayer Select Sinus Pain Relief
Ben-u-ron
Benmyo
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
CCRIS 3
CHEBI:46195
Cadafen
Calapol
Calmanticold
Calonal
Calpol
Capital
Capital with Codeine
Captin
Causalon
Cefalex
Cetadol
Children'S Acetaminophen Elixir Drops
Children'S Acetaminophen Oral Solution
Children'S Tylenol Chewable
Claradol Codeine
Clixodyne
Co-Gesic
Cod-Acamol Forte
Codabrol
Codalgin
Codapane
Codicet
Codisal
Codisal Forte
Codoliprane
Codral Pain Relief
Cofamol
Conacetol
Contac Cough & Sore Throat Formula
Contra-Schmerz P
Coricidin
Coricidin D
Coricidin Sinus
Cosutone
Croix Blanche
Cuponol
Curadon
Curpol
Custodial
D oliprane
Dafalgan
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril Extra-Strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
Dhc Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
Dol-Stop
Dolcor
Dolefin
Dolegrippin
Dolene AP-65
Dolene Ap-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol Forte
Dolorstop
Dolotec
Dolprone
Dorocoff
Dresan
Dristan Cold No Drowsiness
Dristancito
Drixoral Plus
Duaneo
Dularin
Duorol
Duracetamol
Duradyne Dhc
Durapan
Dymadon
Dymadon Co
Dymadon Forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-Plus
Eu-Med
Excedrin
Excedrin Caplets
Excedrin Extra Strength Caplets
Excipain
Exdol
Exdol Strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-Gesic
Febrolin
Femcet
Fendon
Fensum
Fepanil
Fever All
Feverall
Feverall Junior Strength
Feverall Sprinkle Caps Junior Strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon P
Freka-cetamol
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap Children'S Elixir
Genapap Children'S Tablets
Genapap Extra Strength Caplets
Genapap Extra Strength Tablets
Genapap Regular Strength Tablets
Genebs
Genebs Extra Strength Caplets
Genebs Regular Strength Tablets
Genebs X-Tra
Geralgine-P
Gripin Bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hy-Phen
Hycomine Compound
Hydrocet
Ildamol
Inalgex
Infadrops
Infants' Feverall
Influbene N
Injectapap
Intensin
Janupap
Jin Gang
Junior Disprol
KBio1_000660
Kataprin
Kinder Finimal
Korum
Kratofin simplex
L024125
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liqiprine
Liquagesic
Liquigesic Co
Liquiprin
Liquiprin Children'S Elixir
Liquiprin Infants" Drops
Lonarid
Lonarid Mono
Lorcet-Hd
Lortab
Lupocet
Lyteca
Lyteca Syrup
Magnidol
Malex N
Malgis
Malidens
Maxadol
Medigesic Plus
Medinol Paediatric
Medocodene
Melabon Infantil
Mexalen
Midol Maximum Strength
Midol PM Night Time Formula
Midol Regular Strength
Midol Teen Formula
Migraleve Yellow
Minafen
Minoset
Miralgin
Momentum
Mono Praecimed
 
Multin
N-(4-Hydroxyphenyl)acetamide
N-Acetyl-4-aminophenol
N-Acetyl-p-aminophenol
N-acetyl-p-aminophenol
NAPA
NCX 701
NEBS
NSC3991
Naldegesic
Napafen
Napap
Naprinol
Nealgyl
Nebs
Neo-Fepramol
NeoCitran
Neodol
Neodolito
Neopap
Neotrend
Neuridon
New Cortal for Children
NilnOcen
Nina
No-Febril
Nobedon
Nodolex
Noral
Norcet
Norco
O-Acetaminophenol
Ofirmev
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/Apap 500
Oxycodone 5/Apap 500
PCM Paracetamol Lichtenstein
Paceco
Pacemo
Pacemol
Pacet
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine Co
Panadiene
Panado-Co
Panado-Co Caplets
Panadol
Panadol Extra Strength
Panadol Junior Strength Caplets
Panadol Maximum Strength Caplets
Panadol Maximum Strength Tablets
Panale ve
Panaleve
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-Deine #3
Papa-Deine #4
Para-Suppo
Para-Tabs
Paracemol
Paracenol
Paracet
Paracetamol
Paracetamol AL
Paracetamol Antipanin P
Paracetamol BC
Paracetamol Basics
Paracetamol DC
Paracetamol Dr. Schmidgall
Paracetamol Fecofar
Paracetamol Genericon
Paracetamol Hanseler
Paracetamol Harkley
Paracetamol Heumann
Paracetamol Hexal
Paracetamol Italfarmaco
Paracetamol Nycomed
Paracetamol PB
Paracetamol Raffo
Paracetamol Ratiopharm
Paracetamol Rosch
Paracetamol Saar
Paracetamol SmithKline Beecham
Paracetamol Stada
Paracetamol Winthrop
Paracetamol von ct
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Paracétamol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
Paramol
Paramolan
Paranox
Parapan
Parasedol
Parasin
Paraspen
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
Pe-Tam
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-Demi
Percogesic with Codeine
Perdolan Mono
Perfalgan
Phenaphen
Phenaphen Caplets
Phenaphen W/Codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin Forte
Pinex
Piramin
Pirinasol
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet World
Redutemp
Reliv
Remedol
Rhinex D-Lay Tablets
Rivalgyl
Robigesic
Robitussin Night Relief
Rockamol Plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
SK-Apap
SPBio_002836
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten Rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sine-Off Sinus Medicine Caplets
Sinedol
Sinmol
Sinubid
Snaplets-FR
Spalt N
Spalt fur die nacht
St Joseph Aspirin-Free
St Joseph Aspirin-Free for Children
St. Joseph Cold Tablets for Children
St. Joseph Fever Reducer
Stanback
Stopain
Sudafed Severe Cold Formula
Sudafed Sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-M
Synalgos-Dc-A
TYL
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol Extra Strength Caplets
Tapanol Extra Strength Tablets
Tapar
Tavist Allergy/Sinus/Headache
Tazamol
Temlo
Tempanal
Tempra
Tempra Caplets
Tempra Chewable Tablets
Tempra D.S
Tempra Drops
Tempra Syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
Tizide
Tocris-1706
Toximer P
Tralgon
Treupel N
Treupel mon
Treuphadol
Triad
Triaminic Sore Throat Formula
Triaprin
Tricoton
Tussapap
Ty lenol
Tycolet
Tylenol
Tylenol (TN)
Tylenol Allergy Sinus
Tylenol Arthritis Extended Relief
Tylenol Caplets
Tylenol Children'S Chewable Tablets
Tylenol Children'S Elixir
Tylenol Children'S Suspension Liquid
Tylenol Drops
Tylenol Elixir
Tylenol Extra Strength Adult Liquid Pain Reliever
Tylenol Extra Strength Caplets
Tylenol Extra Strength Gelcaps
Tylenol Extra Strength Tablets
Tylenol Gelcaps
Tylenol Infants Drops
Tylenol Infants" Suspension Drops
Tylenol Junior Strength Caplets
Tylenol Junior Strength Chewable Tablets
Tylenol Regular Strength Caplets
Tylenol Regular Strength Tablets
Tylenol Tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin Extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor Richet
Vicodin
Vicodin Es
Vicodin Hp
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
acetaminofén
acétaminophène
alpha-Per
p-(Acetylamino)phenol
p-Acetamidophenol
p-Acetaminophenol
p-Acetylaminophenol
p-Hydroxyacetanilide
p-Hydroxyphenolacetamide
p-acetamidophenol
p-acetaminophenol
p-hydroxy-acetanilid
p-hydroxyacetanilide
p-hydroxyphenolacetamide
4
WarfarinapprovedPhase 4, Phase 345481-81-26691, 54678486
Synonyms:
(-)-Warfarin
(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone
(S)-Warfarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine
1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone
200 Coumarin
200 coumarin
3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin
3-(Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin
3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin
4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin
4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine
45706_FLUKA
45706_RIEDEL
4oh-coumarin deriv.
5543-56-6
5543-57-7
81-81-2
A2250_FLUKA
A2250_SIGMA
AC-15978
AC1L1N37
AC1Q6AN3
AR-1E2310
Arab Rat Death
Arab rat death
Arab rat deth
Athrombin
Athrombin-K
Athrombin-k
Athrombine-K
Athrombine-k
BRD-A24514565-001-02-2
BRD-A24514565-236-01-6
BRN 1293536
BSPBio_002026
Bio-0586
Brumolin
C01541
C19H16O4
CBDivE_002127
CBDivE_013236
CBKinase1_000192
CBKinase1_012592
CHEBI:10033
CHEMBL1464
CID6691
CO-Rax
Caswell No. 903
Choice
Choice (TN)
Co-Rax
Co-rax
Compound 42
Coumadin
Coumadin Tabs
Coumafen
Coumafene
Coumafene [French]
Coumaphen
Coumaphene
Coumarins
Coumefene
Cov-R-Tox
Cov-R-tox
D-Con
D08682
DB00682
DL-3-(alpha-acetonylbenzyl)-4-hydroxycoumarin
Dethmor
Dethnel
Dicusat E
Dicusat e
DivK1c_000444
EINECS 201-377-6
EINECS 226-907-3
EPA Pesticide Chemical Code 086002
Eastern states duocide
Fasco fascrat powder
Frass-Ratron
Frass-ratron
HMS1921K07
HMS2092C20
HMS501G06
HSDB 1786
I14-0958
IDI1_000444
Jantoven
KBio1_000444
KBio2_000674
KBio2_003242
KBio2_005810
KBio3_001526
KBioGR_000901
KBioSS_000674
Killgerm sewarin p
Kumader
Kumadu
Kumatox
Kypfarin
LS-55083
Latka 42
Latka 42 [Czech]
Liqua-tox
MLS001304042
Maag Rattentod Cum
Maag rattentod cum
Mar-Frin
Mar-frin
Marevan
Martin'S mar-frin
Martin's mar-frin
 
Maveran
MolPort-001-787-822
Mouse pak
NCGC00094810-01
NCGC00094810-02
NCGC00159398-03
NCGC00178855-01
NINDS_000444
NSC 59813
NSC59813
PS104_SUPELCO
Panwarfin
Place-Pax
Place-pax
Prothromadin
RAX
RCR grey squirrel killer concentrate
RCRA waste no. P001
Rat & mice bait
Rat and mice bait
Rat-B-gon
Rat-Gard
Rat-Kill
Rat-Mix
Rat-O-cide #2
Rat-O-cide no. 2
Rat-Ola
Rat-Trol
Rat-a-way
Rat-alpha-way
Rat-b-gon
Rat-beta-gon
Rat-gard
Rat-kill
Rat-mix
Rat-o-cide #2
Rat-ola
Rat-trol
Ratorex
Ratox
Ratoxin
Ratron
Ratron G
Ratron g
Rats-no-more
Ratten-Koederrohr
Ratten-koederrohr
Rattenstreupulver Neu Schacht
Rattenstreupulver neu schacht
Rattenstreupulver new schacht
Rattentraenke
Rattunal
Rcra waste number P001
Ro-Deth
Ro-deth
Rodafarin
Rodafarin C
Rodafarin c
Rodex
Rodex blox
Rosex
Rough & ready mouse mix
Rough and ready mouse mix
SMP1_000316
SMR000718754
SPBio_000870
SPECTRUM1500613
STK364490
Sakarat
Sewarin
Sofarin
Solfarin
Sorexa Plus
Sorexa plus
Spectrum2_000935
Spectrum3_000583
Spectrum4_000381
Spectrum5_001751
Spectrum_000194
Spray-trol brand roden-trol
Temus W
Temus w
Tintorane
Tox-Hid
Tox-hid
Twin light rat away
UNII-5Q7ZVV76EI
Vampirinip II
Vampirinip III
Vampirinip iii
W.A.R.F. 42
WARF compound 42
WLN: T66 BOVJ DYR&1V1 EQ
Waran
Warf 10
Warf 42
Warfarat
Warfarin (INN)
Warfarin (and salts of)
Warfarin Plus
Warfarin Q
Warfarin [BSI:ISO]
Warfarin [INN:BAN]
Warfarin plus
Warfarin plus [discontinued]
Warfarin sodium
Warfarin titrated to an INR of 2.5-3.0
Warfarin(R)
Warfarina
Warfarina [INN-Spanish]
Warfarine
Warfarine [INN-French]
Warfarine [ISO-French]
Warfarinum
Warfarinum [INN-Latin]
Warficide
Warfilone
Zoocoumarin
Zoocoumarin [Netherlands and USSR]
Zoocoumarin [Russian]
delta-Con
nchembio.307-comp19
rac-Warfarin
warfarin
5
RivaroxabanapprovedPhase 4, Phase 3244366789-02-8
Synonyms:
BAY 59-7939
 
BAY59-7939
Xarelto
6
ApixabanapprovedPhase 4134503612-47-310182969
Synonyms:
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahyd
2p16
503612-47-3
AKOS005146204
Apixaban
Apixaban (JAN/USAN/INN)
BMS 562247-01
BMS-562247
BMS-562247-01
BMS-562247-01, Apixaban
 
CHEBI:49620
CHEMBL231779
CID10182969
D03213
DB07828
GG2
S1593_Selleck
UNII-3Z9Y7UWC1J
apixabanum
apixabán
ro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide
7
Folic Acidapproved, nutraceutical, vet_approvedPhase 4427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
8Heparin, Low-Molecular-WeightPhase 4, Phase 2320
9ImmunoglobulinsPhase 4, Phase 3, Phase 2, Phase 16045
10AnticoagulantsPhase 4, Phase 3, Phase 22516
11VaccinesPhase 4, Phase 16428
12calcium heparinPhase 4, Phase 1, Phase 2812
13Antibodies, AntiphospholipidPhase 4, Phase 3, Phase 229
14Fibrinolytic AgentsPhase 4, Phase 22317
15AntibodiesPhase 4, Phase 3, Phase 2, Phase 16045
16AnalgesicsPhase 4, Phase 211287
17AntipyreticsPhase 4, Phase 21534
18Peripheral Nervous System AgentsPhase 4, Phase 222776
19Analgesics, Non-NarcoticPhase 4, Phase 26260
20VitaminsPhase 45095
21HematinicsPhase 41630
22Trace ElementsPhase 45802
23MicronutrientsPhase 45802
24Vitamin B ComplexPhase 44229
25HIV Protease InhibitorsPhase 4, Phase 35319
26
protease inhibitorsPhase 4, Phase 35320
Synonyms:
 
protease inhibitors
27Factor Xa InhibitorsPhase 4, Phase 3391
28Serine Proteinase InhibitorsPhase 4, Phase 3850
29AntithrombinsPhase 4, Phase 3672
30Antithrombin IIIPhase 4, Phase 3665
31FolateNutraceuticalPhase 44279
32Folinic AcidNutraceuticalPhase 43150
33Vitamin B9NutraceuticalPhase 44279
34serineNutraceuticalPhase 4, Phase 3921
35
HydroxychloroquineapprovedPhase 3, Phase 2146118-42-33652
Synonyms:
(+-)-Hydroxychloroquine
(±)-hydroxychloroquine
118-42-3
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol
2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol
5-22-10-00280 (Beilstein Handbook Reference)
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline
7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
747-36-4 (sulfate (1:1) salt)
AC1L1GEW
BRN 0253894
C07043
C18H26ClN3O
CHEMBL1535
CID3652
D08050
DB01611
DivK1c_000942
EINECS 204-249-8
Gen-Hydroxychloroquine 200mg Tablets
HCQ
HMS502P04
Hidroxicloroquina
 
Hidroxicloroquina [INN-Spanish]
Hydroxychlorochin
Hydroxychloroguine
Hydroxychloroquine (INN)
Hydroxychloroquine Sulfate (1:1) Salt
Hydroxychloroquine [INN:BAN]
Hydroxychloroquinum
Hydroxychloroquinum [INN-Latin]
IDI1_000942
Idrossiclorochina
Idrossiclorochina [DCIT]
KBio1_000942
LS-66614
MolPort-003-847-792
NCGC00159483-02
NINDS_000942
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
PlaqueN/A
Polirreumin
Polirreumin (TN)
Quensyl
SPBio_001116
ST072188
Spectrum2_001238
Spectrum5_001697
UNII-4QWG6N8QKH
WIN 1258
hydroxychloroquine
36
AcenocoumarolapprovedPhase 332152-72-79052, 54676537
Synonyms:
152-72-7
2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-4h-chromen-4-one
2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one
3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin
3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin
3-(alpha-(p-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin
3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin
3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin
3-(alpha-Acetonyl-p-nitrobenzyl)-4-hydroxycoumarin
3-(alpha-Acetonyl-para-nitrobenzyl)-4-hydroxy-coumarin
3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin
3-(alpha-p-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin
4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one
70897-81-3
AB-014/25000129
AB00513804
AC1L1S7P
AC1Q1Z5F
ACENOCOUMAROL
AR-1E2350
Acenocoumarin
Acenocoumarol (INN)
Acenocoumarol Alliance Brand
Acenocoumarol Ciba-Geigy Brand
Acenocoumarol Novartis Brand
Acenocoumarol [INN]
Acenocoumarolum
Acenocoumarolum [INN-Latin]
Acenocoumarolum [INN-latin]
Acenocoumarolum [inn-latin]
Acenocumarol
Acenocumarolo
Acenocumarolo [DCIT]
Acenocumarolum
Acenokumarin
Acenokumarin [Czech]
Alliance Brand of Acenocoumarol
Ascumar
BPBio1_000110
BRD-A65051990-001-03-8
BSPBio_000100
C19H15NO6
CHEBI:53766
CHEMBL145253
CHEMBL397420
CID9052
 
Ciba Geigy Brand of Acenocoumarol
Ciba-Geigy Brand of Acenocoumarol
D000074
D07064
DB01418
EINECS 205-807-3
G 23350
G-23,350
G-23350
G23350
HMS1568E22
HSDB 3201
Jsp002948
LS-55093
MLS000539171
MLS001074461
Mini Sintrom
Mini-sintrom
Mini-sintrom (TN)
Minisintrom
MolPort-002-798-798
NCGC00179658-01
Neositron
Nicoumalone
Nicumalon
Nitrophenylacetylethyl-4-hydroxycoumarine
Nitrovarfarian
Nitrowarfarin
Novartis Brand of Acenocoumarol
Prestwick0_000110
Prestwick1_000110
Prestwick2_000110
Prestwick3_000110
Prestwick_773
SMR000162652
SPBio_002039
Sincoumar
Sinkumar
Sinthrom
Sinthrome
Sintrom
Sintroma
Syncoumar
Syncumar
Synthrom
Syntrom
UNII-I6WP63U32H
Zotil
37AutoantibodiesPhase 3, Phase 1126
38Antirheumatic AgentsPhase 3, Phase 2, Phase 110627
39AntimalarialsPhase 3, Phase 21216
40Antiprotozoal AgentsPhase 3, Phase 21986
41Anti-Infective AgentsPhase 3, Phase 221402
42Antiparasitic AgentsPhase 3, Phase 22127
43
Aspirinapproved, vet_approvedPhase 1, Phase 2111250-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoic acid
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide 2-(acetyloxy)benzoique
Acide acetylsalicylique
Acide acétylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
 
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
ácido acetilsalicílico
44
FluvastatinapprovedPhase 25893957-54-11548972
Synonyms:
(+)-(3R,5S)-fluvastatin
(-)-(3S,5R)-fluvastatin
(3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid
(3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid
(Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid
7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate
7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid
93957-54-1
AC1L1FUW
AC1L3TXK
AC1L9J7I
AC1LU7LJ
AC1NS4EB
AC1OC9O5
AC1Q1PZO
BIDD:GT0839
BPBio1_000965
BRD-K03602135-236-02-1
BSPBio_000877
C07014
C24H26FNO4
CHEBI:38562
CHEBI:38565
CHEBI:38567
CHEBI:5136
CHEMBL1078
CHEMBL170417
CID10501876
CID146801
CID1548972
 
CID3403
CID446155
CID5353627
CID6914285
CID9887837
CPD001453708
Canef
Cranoc
D07983
DB01095
Fluindostatin
Fluvas
Fluvas (TN)
Fluvastatin & Primycin
Fluvastatin (INN)
Fluvastatin [INN:BAN]
Fluvastatina
Fluvastatina [INN-Spanish]
Fluvastatine
Fluvastatine [INN-French]
Fluvastatinum
Fluvastatinum [INN-Latin]
HMS2089P06
I06-2297
LS-7404
Lescol
Lescol XL
MolPort-003-847-470
Prestwick0_000859
Prestwick1_000859
Prestwick2_000859
Prestwick3_000859
SAM002548940
SPBio_002798
T6624179
TL8005940
UNII-4L066368AS
XU 62320
XU-62320
fluvastatin
fluvastatin sodium
nchembio.301-comp9
nchembio790-comp18
45
rituximabapprovedPhase 21654174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
46Calcium, DietaryPhase 25525
47AntimetabolitesPhase 211774
48Anticholesteremic AgentsPhase 21983
49Lipid Regulating AgentsPhase 22702
50Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 21956

Interventional clinical trials:

(show top 50)    (show all 55)
idNameStatusNCT IDPhase
1Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic DiseasesUnknown statusNCT01151644Phase 4
2Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid AntibodiesCompletedNCT01608347Phase 4
3Drug Interaction Between Paracetamol and WarfarinCompletedNCT01104337Phase 4
4Apixaban for the Secondary Prevention of Thromboembolism Among Patients With the AntiphosPholipid SyndromeRecruitingNCT02295475Phase 4
5Rivaroxaban for Antiphospholipid Antibody SyndromeRecruitingNCT02116036Phase 4
6Use of Warfarin After the First Trimester in Pregnant Women With APSRecruitingNCT02303171Phase 4
7Timing of Initiation of LMWH Administration in Pregnant Women With APSRecruitingNCT02326051Phase 4
8Rivaroxaban in Thrombotic Antiphospholipid SyndromeRecruitingNCT02157272Phase 3
9Evaluation of the Duration of Therapy for Thrombosis in ChildrenRecruitingNCT00687882Phase 3
10Rivaroxaban for Patients With Antiphospholipid SyndromeActive, not recruitingNCT02926170Phase 3
11Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive PatientsTerminatedNCT01784523Phase 3
12Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome PatientsUnknown statusNCT00674297Phase 2
13Steroids and Antiphospholipid Syndrome- Related Pregnancy LossUnknown statusNCT00180778Phase 1, Phase 2
14A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid SyndromeCompletedNCT00537290Phase 2
15Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid SyndromeCompletedNCT01051778Phase 2
16Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid SyndromeCompletedNCT02128269Phase 2
17Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid SyndromeRecruitingNCT02595346Phase 2
18Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody SyndromeActive, not recruitingNCT01029587Phase 2
19Infections and Autoimmunity: Autobodies Screening in Multiple SclerosisUnknown statusNCT00230204Phase 1
20Safety and Immunogenicity of a Vaccine Dendritic Cell-based Pulsed With Autologous Heat-inactivated in HIV-1 Infected PatientsNot yet recruitingNCT02767193Phase 1
21Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune DiseasesTerminatedNCT00849745Phase 1
22Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid SyndromeWithdrawnNCT00278616Phase 1
23Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid SyndromeUnknown statusNCT01661439
24Antiphospholipid Antibodies and Early Severe Preeclampsia.Unknown statusNCT01538121
25Antiphospholipid Antibodies and Fetal Growth RestrictionUnknown statusNCT01538134
26Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.Unknown statusNCT00180817
27Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)Unknown statusNCT01475149
28The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic SyndromeUnknown statusNCT01818505
29Beneficial Effects of Coenzyme Q10 Treatment on the Mitochondrial Dysfunction and Oxidative Stress Associated to Atherothrombosis Developement in Antiphospholipidid Syndrome PatientsUnknown statusNCT02218476
30Monitoring Anticoagulant Therapy in Antiphospholipid SyndromeCompletedNCT01660061
31Antiphospholipid Syndrome Collaborative Registry (APSCORE)CompletedNCT00076713
32Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With WarfarinCompletedNCT00878137
33The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International RCompletedNCT02855047
34CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) PatientsCompletedNCT02139072
35Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid SyndromeCompletedNCT02833194
36Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody SyndromeCompletedNCT00010400
37Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)CompletedNCT02892565
38CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and AcetaminophenCompletedNCT01762891
39Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in PregnancyCompletedNCT00721591
40Clinical Significance of Antiphospholipid Antibodies in Healthy SubjectsCompletedNCT02803645
41Pharmacogenetics of Warfarin in Puerto Ricans.CompletedNCT01318057
42Walking and Dietary Modification for Recurrent Early MiscarriagesCompletedNCT03023137
43Centralized Reading Assessment of Chronic CerebroSpinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis and Other Neurological DiseasesCompletedNCT02308579
44Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During PregnancyCompletedNCT00930397
45Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally StudyRecruitingNCT00616317
46Genetic Risk Factors Associated With Antiphospholipid Antibody SyndromeRecruitingNCT00482794
47Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)RecruitingNCT00198068
48Pregnancy and Medically Assisted Conception in Rare DiseasesRecruitingNCT02450396
49Phenomics in Autoimmune and Inflammatory DiseasesRecruitingNCT02466217
50Pilot Study of Gut Commensals in Antiphospholipid SyndromeActive, not recruitingNCT01787305

Search NIH Clinical Center for Antiphospholipid Syndrome


Cochrane evidence based reviews: antiphospholipid syndrome

Genetic Tests for Antiphospholipid Syndrome

About this section

Anatomical Context for Antiphospholipid Syndrome

About this section

MalaCards organs/tissues related to Antiphospholipid Syndrome:

36
Brain, Endothelial, Testes, Bone, Monocytes, Heart, Skin

Publications for Antiphospholipid Syndrome

About this section

Articles related to Antiphospholipid Syndrome:

(show top 50)    (show all 1402)
idTitleAuthorsYear
1
Fatal antiphospholipid syndrome following endoscopic transnasal-transsphenoidal surgery for a pituitary tumor: A case report. (28072724)
2017
2
Thrombotic management of antiphospholipid syndrome: Towards novel targeted therapies. (28056758)
2017
3
Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients. (28050648)
2017
4
Cellular immune response to I^2-glycoprotein-I valine/leucine(247) phenotypes in Mexican patients with primary antiphospholipid syndrome. (28038927)
2017
5
Dental care in patients with antiphospholipid syndrome: two case reports. (28068274)
2017
6
Atypical bone change of spine caused by epidural venous thrombosis in systemic lupus erythematosus with antiphospholipid syndrome. (28063414)
2017
7
In Vitro Fertilization in 37 Women with Systemic Lupus Erythematosus or Antiphospholipid Syndrome: A Series of 97 Procedures. (28089975)
2017
8
Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population? (27032789)
2016
9
Successful Anticoagulation Therapy for Antiphospholipid Syndrome with Mobile Aortic Thrombi. (28042559)
2016
10
Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: A cohort study. (27599157)
2016
11
Lupus anticoagulant-hypoprothrombinemia syndrome and catastrophic antiphospholipid syndrome in a patient with antidomain I antibodies. (27380476)
2016
12
Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome. (28000012)
2016
13
Catastrophic antiphospholipid syndrome in pregnancy, a diagnosis that should not be missed. (27023104)
2016
14
Treatment of catastrophic antiphospholipid syndrome. (26927441)
2016
15
Pregnancy outcomes of antiphospholipid syndrome: In a low resource South Asian setting. (27512499)
2016
16
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry. (27639837)
2016
17
RETINAL DEEP CAPILLARY PLEXUS ISCHEMIA IN A CASE WITH ANTIPHOSPHOLIPID SYNDROME. (28005581)
2016
18
'Non-criteria' neurologic manifestations of antiphospholipid syndrome: A hidden kingdom to be discovered. (27658514)
2016
19
Systematic review of case reports of antiphospholipid syndrome following infection. (27060064)
2016
20
AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update. (27646150)
2016
21
Surgical treatment of chronic multivascular mesenteric ischemia in a patient with antiphospholipid syndrome, abdominal aortic aneurism, and renal cancer: when planning overwhelms complexity. (27941240)
2016
22
Cardiac thrombus with risk of fulminant pulmonary embolism in paediatric antiphospholipid syndrome. (27138626)
2016
23
Rivaroxaban limits complement activation compared to warfarin in antiphospholipid syndrome patients with venous thromboembolism. (27541499)
2016
24
Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome. (27826173)
2016
25
EP17.21: Uterine artery Doppler and triple marker positivity for the detection of adverse pregnancy outcome in primary antiphospholipid syndrome. (27645511)
2016
26
Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients. (27562033)
2016
27
Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208A cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort. (27401589)
2016
28
ANNALS EXPRESS: ANTIPHOSPHOLIPID AND ANTIOANGIOGENIC ACTIVITY IN WOMEN WITH RECURRENT MISCARRIAGE AND ANTIPHOSPHOLIPID SYNDROME. (27638930)
2016
29
Current status and future prospects for the treatment of antiphospholipid syndrome. (27117597)
2016
30
Catastrophic antiphospholipid syndrome after cardiac surgery. (27455170)
2016
31
Antiphospholipid syndrome and kidney disease. (27555120)
2016
32
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial. (27570089)
2016
33
A 37-year-old man with primary antiphospholipid syndrome presenting with respiratory distress and worsening toe ischemia. (27992694)
2016
34
Uterine Artery Embolization Resulting in Catastrophic Antiphospholipid Syndrome in a Patient with Primary Antiphospholipid Syndrome. (27106650)
2016
35
Characteristics of Chinese patients with antiphospholipid syndrome and the ability of lupus anticoagulant assays to identify them. (27096780)
2016
36
A rare combination of thrombotic thrombocytopenic purpura and antiphospholipid syndrome. (27898514)
2016
37
Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre. (27639925)
2016
38
Successful treatment with thrombolysis and stent in acute limb ischemia complicating antiphospholipid syndrome. (27057937)
2016
39
Takayasu's arteritis and primary antiphospholipid syndrome presenting as hypertensive urgency. (26783006)
2016
40
Ischemic gastrointestinal manifestations in a young adult: Implicating a rare initial presentation of antiphospholipid syndrome. (27029604)
2016
41
Probable catastrophic antiphospholipid syndrome (CAPS) in case of SLE. (27728684)
2016
42
Plasma Exchange in the Management of Catastrophic Antiphospholipid Syndrome. (27833765)
2016
43
Vitamin D deficiency in antiphospholipid syndrome. (27994369)
2016
44
Antiphospholipid syndrome with subsequent chronic discoid lupus erythematosus: a case report. (27068596)
2016
45
Significance of fully automated tests for the diagnosis of antiphospholipid syndrome. (27552227)
2016
46
What is known about pediatric antiphospholipid syndrome? (27615277)
2016
47
Myocardial Ischaemia, Coronary Atherosclerosis and Pulmonary Pressure Elevation in Antiphospholipid Syndrome Patients. (28028974)
2016
48
Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study. (27510605)
2016
49
Catastrophic Antiphospholipid Syndrome Triggered by Fulminant Chikungunya Infection in a Patient With Systemic Lupus Erythematosus. (26748818)
2016
50
Reply to: "Monitoring antivitamin K anticoagulants in antiphospholipid syndrome: A challenge in quality". (27993386)
2016

Variations for Antiphospholipid Syndrome

About this section

Copy number variations for Antiphospholipid Syndrome from CNVD:

6
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1160790221630000024300000DeletionHughes'' syndrome

Expression for genes affiliated with Antiphospholipid Syndrome

About this section
Search GEO for disease gene expression data for Antiphospholipid Syndrome.

Pathways for genes affiliated with Antiphospholipid Syndrome

About this section

GO Terms for genes affiliated with Antiphospholipid Syndrome

About this section

Cellular components related to Antiphospholipid Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1intrinsic component of external side of plasma membraneGO:003123310.6F10, F3
2extracellular matrixGO:00310129.9APOH, F2, F3, PLAT
3endoplasmic reticulum lumenGO:00057889.9ADAMTS13, F10, F2, F5
4external side of plasma membraneGO:00098979.5ANXA5, CD40LG, CD79A, SELP
5cell surfaceGO:00099868.9ADAMTS13, APOH, CD40LG, F3, PLAT, THBD
6extracellular spaceGO:00056156.7ADAMTS13, APOH, CD40LG, F2, F3, F5
7plasma membraneGO:00058866.2APOH, CD40LG, CD79A, F10, F2, F3

Biological processes related to Antiphospholipid Syndrome according to GeneCards Suite gene sharing:

(show all 17)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of blood coagulationGO:003019410.6APOH, F2
2regulation of blood coagulationGO:003019310.6APOH, F2
3blood coagulation, extrinsic pathwayGO:000759810.5F10, F3
4peptidyl-glutamic acid carboxylationGO:001718710.5F10, F2
5negative regulation of platelet activationGO:001054410.4F2, THBD
6fibrinolysisGO:004273010.3F2, PLAT
7plasminogen activationGO:003163910.3APOH, PLAT
8blood coagulation, intrinsic pathwayGO:000759710.3APOH, F10, F2
9negative regulation of fibrinolysisGO:005191810.1APOH, F2, THBD
10negative regulation of blood coagulationGO:003019510.1ANXA5, APOH, THBD
11platelet activationGO:00301689.8ADAMTS13, CD40LG, F2, F5
12leukocyte tethering or rollingGO:00509019.8SELE, SELP
13platelet degranulationGO:00025769.7APOH, F5, SELP
14leukocyte cell-cell adhesionGO:00071599.5CD40LG, SELE, SELP
15leukocyte migrationGO:00509009.0F2, SELE, SELP, THBD
16response to lipopolysaccharideGO:00324968.4F3, SELE, SELP, THBD
17blood coagulationGO:00075968.2ANXA5, F10, F2, F3, F5, PLAT

Molecular functions related to Antiphospholipid Syndrome according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1phospholipid bindingGO:000554310.1ANXA5, APOH, F10, F3
2oligosaccharide bindingGO:007049210.0SELE, SELP
3glycoprotein bindingGO:00019489.6APOH, PLAT, SELP
4calcium ion bindingGO:00055099.4ADAMTS13, ANXA5, F10, F2, THBD
5sialic acid bindingGO:00336919.1SELE, SELP
6serine-type endopeptidase activityGO:00042528.8F10, F2, F3, F5, PLAT
7protein bindingGO:00055155.5ADAMTS13, ANXA5, APOH, CD40LG, CD79A, F10

Sources for Antiphospholipid Syndrome

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet